Faruqi & Faruqi, LLP is Investigating Keryx Biopharmaceuticals, Inc. (KERX) on Behalf of its Shareholders

News provided by

Jul 16, 2015, 05:50 ET

NEW YORK, July 16, 2015 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential wrongdoing at Keryx Biopharmaceuticals, Inc. ("Keryx " or the "Company") (Nasdaq: KERX).

The investigation focuses on whether the Company and its officers breached their fiduciary duties with respect to the Keryx's corporate governance controls.

Request more information now by clicking here: www.faruqilaw.com/KERX. There is no cost or obligation to you.

Take Action

If you currently own Keryx stock and have continuously owned Keryx stock and would like to discuss your legal rights, please visit www.faruqilaw.com/KERX. You can also contact us by calling Nadeem Faruqi toll free at (212) 983-9330 or by sending an e-mail to [email protected]. Faruqi & Faruqi, LLP also encourages anyone with information regarding Keryx's conduct to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

FARUQI & FARUQI, LLP
369 Lexington Avenue, 10th Floor
New York, NY 10017
Attn: Nadeem Faruqi
[email protected]
Telephone: (212) 983-9330

Logo - http://photos.prnewswire.com/prnh/20120119/MM38856LOGO

SOURCE Faruqi & Faruqi, LLP